Combined larynx large cell neuroendocrine and squamous cell carcinoma: a case report
Open Access
- 23 November 2023
- journal article
- research article
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 21, eRC0618
Abstract
Laryngeal cancer ranks third among the most common head and neck neoplasms. The most common histological subtype is squamous cell carcinoma, and neuroendocrine tumors are rare. An even rarer entity is a composite tumor with both these histologies. This case reports a metastatic combined carcinoma of squamous cells and large neuroendocrine cells, presenting favorable response to treatment with a total laryngectomy followed by adjuvant therapy including chemo-, radio-, and immunotherapy. Combined larynx large cell neuroendocrine and squamous cell carcinoma:Keywords
This publication has 8 references indexed in Scilit:
- Large cell neuroendocrine carcinoma originating in the subglottic larynxEar, Nose & Throat Journal, 2022
- Update on Neuroendocrine Carcinomas of the LarynxAmerican Journal of Clinical Pathology, 2019
- Systemic therapy in non-conventional cancers of the larynxOral Oncology, 2018
- How phenotype guides management of the neuroendocrine carcinomas of the larynxThe Journal of Laryngology & Otology, 2018
- Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal SpaceHead and Neck Pathology, 2017
- An update on larynx cancerCA: A Cancer Journal for Clinicians, 2016
- Pembrolizumab (Keytruda)Human Vaccines & Immunotherapeutics, 2016
- Clinical recommendations on the treatment of neuroendocrine carcinoma of the larynx: A meta-analysis of 436 reported casesHead & Neck, 2014